Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

SELL
$137.6 - $154.97 $963 - $1,084
-7 Reduced 0.34%
2,065 $320,000
Q3 2023

Nov 01, 2023

SELL
$133.59 - $154.65 $2,938 - $3,402
-22 Reduced 1.05%
2,072 $308,000
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $2,385 - $2,968
-18 Reduced 0.85%
2,094 $282,000
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $78,667 - $90,597
-544 Reduced 20.48%
2,112 $336,000
Q4 2022

Jan 25, 2023

SELL
$138.31 - $165.87 $829 - $995
-6 Reduced 0.23%
2,656 $429,000
Q3 2022

Nov 04, 2022

SELL
$134.21 - $153.93 $71,668 - $82,198
-534 Reduced 16.71%
2,662 $357,000
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $2,890 - $3,674
-21 Reduced 0.65%
3,196 $489,000
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $32,863 - $40,773
-249 Reduced 7.18%
3,217 $522,000
Q4 2021

Feb 03, 2022

SELL
$107.43 - $135.93 $644 - $815
-6 Reduced 0.17%
3,466 $469,000
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $57,456 - $65,221
540 Added 18.42%
3,472 $375,000
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $736 - $820
7 Added 0.24%
2,932 $330,000
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $174,830 - $192,467
-1,709 Reduced 36.88%
2,925 $317,000
Q4 2020

Jan 27, 2021

SELL
$80.49 - $108.67 $5,795 - $7,824
-72 Reduced 1.53%
4,634 $497,000
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $24,398 - $28,635
-284 Reduced 5.69%
4,706 $412,000
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $65,519 - $87,674
893 Added 21.8%
4,990 $490,000
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $264,256 - $400,645
4,097 New
4,097 $312,000
Q2 2019

Jul 19, 2019

SELL
$65.7 - $83.98 $250,776 - $320,551
-3,817 Closed
0 $0
Q1 2019

Apr 24, 2019

BUY
$77.14 - $90.79 $28,001 - $32,956
363 Added 10.51%
3,817 $308,000
Q4 2018

Jan 23, 2019

BUY
$77.85 - $96.01 $268,893 - $331,618
3,454 New
3,454 $318,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jgp Global Gestao De Recursos Ltda. Portfolio

Follow Jgp Global Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.